Matthew E. Burow
9Patents
2h-index
24Co-inventors
43Inventor score
Filing activity: Feb 18, 2008 → Jan 15, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9227898B2 | Postharvest production and enhancement of resveratrol and piceatannol in sugarcane | Emerging Cross-Sectional Technologies | 5 | Active |
| US8987198B2 | Compositions and methods for treating obesity and diabetes | Human Necessities | 3 | Active |
| US8962679B2 | Daidzein analogs as treatment for cancer | Chemistry; Metallurgy | 2 | Active |
| US8323706B2 | Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis | Human Necessities | 1 | Active |
| US7879369B2 | Combretum laurifolium Mart. extract and methods of extracting and using such extract | Human Necessities | 1 | Active |
| US9669004B2 | Daidzein analogs as treatment for cancer | Chemistry; Metallurgy | 1 | Active |
| US11465978B2 | Anthranilic amides and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US11098053B2 | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | Human Necessities | 0 | Active |
| US8563599B2 | Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.